Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: A report from the childhood cancer survivor study

Pediatric Blood and Cancer

Volumn 53, Issue 3, 2009, Pages 432-437

  Chow, Eric J ^a,b   Friedman, Debra L ^c   Stovall, Marilyn ^d   Yasui, Yutaka ^e   Whitton, John A ^b   Robison, Leslie L ^f   Sklar, Charles A ^g  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Hyperthyroidism; Hypothyroidism; Late effects; Leukemia; Radiation; Thyroid cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVOR; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DOSIMETRY; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RISK ASSESSMENT; SCHOOL CHILD; SELF REPORT; SIBLING; SKULL IRRADIATION; THYROID CANCER;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS; SURVIVORS; THYROID DISEASES; THYROID NEOPLASMS;

EID: 67651242358     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22082     Document Type: Article

References (29)

1. Ogilvy-Stuart AL, Shalet SM, Gattamaneni HR. Thyroid function after treatment of brain tumors in children. J Pediatr 1991;119: 733-737.
2. Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, et al. A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor. J Clin Endocrinol Metab 2003;88:136-140. (Pubitemid 36115155)
3. Sklar C, Whitton J, Mertens A, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: Data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000;85:3227-3232. (Pubitemid 30944530)
4. Nygaard R, Bjerve KS, Kolmannskog S, et al. Thyroid function in children after cytostatic treatment for acute leukemia. Pediatr Hematol Oncol 1988;5:35-38. (Pubitemid 18119456)
5. Lando A, Holm K, Nysom K, et al. Thyroid function in survivors of childhood acute lymphoblastic leukaemia: The significance of prophylactic cranial irradiation. Clin Endocrinol (Oxf) 2001;55: 21-25. (Pubitemid 34204295)
6. Shalet SM, Beardwell CG, Twomey JA, et al. Endocrine function following the treatment of acute leukemia in childhood. J Pediatr 1977;90:920-923.
7. Pasqualini T, McCalla J, Berg S, et al. Subtle primary hypothyroidism in patients treated for acute lymphoblastic leukemia. Acta Endocrinol (Copenh) 1991;124:375-380.
8. Mohn A, Chiarelli F, Di Marzio A, et al. Thyroid function in children treated for acute lymphoblastic leukemia. J Endocrinol Invest 1997;20:215-219. (Pubitemid 27289382)
9. Sigurdson AJ, Ronckers CM, Mertens AC, et al. Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): A nested case-control study. Lancet 2005;365: 2014-2023.
10. Maule M, Scelo G, Pastore G, et al. Risk of second malignant neoplasms after childhood leukemia and lymphoma: An international study. J Natl Cancer Inst 2007;99:790-800. (Pubitemid 47073525)
11. Margolin JF, Steuber CP, Poplack DG. Acute lymphoblastic leukemia. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2006. pp. 538-590.
12. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: A multi-institutional collaborative project. Med Pediatr Oncol 2002;38: 229-239.
13. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study. J Natl Cancer Inst 2001;93:618-629. (Pubitemid 32409629)
14. Stovall M, Weathers R, Kasper C, et al. Dose reconstruction for therapeutic and diagnostic radiation exposures: Use in epidemiological studies. Radiat Res 2006;166:141-157. (Pubitemid 44051207)
15. Breslow NE, Day NE. Statistical methods in cancer research. Volume II - The design and analysis of cohort studies. Lyon: IARC Sci Publ; 1987. 406 p.
16. Rose SR, Lustig RH, Pitukcheewanont P, et al. Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 1999;84:4472-4479. (Pubitemid 30677662)
17. Bessho F, Ohta K, Akanuma A, et al. Dosimetry of radiation scattered to thyroid gland from prophylactic cranial irradiation for childhood leukemia. Pediatr Hematol Oncol 1994;11:47-53. (Pubitemid 24026978)
18. Stevens G, Downes S, Ralston A. Thyroid dose in children undergoing prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1998;42:385-390. (Pubitemid 28502787)
19. Madanat LM, Lahteenmaki PM, Alin J, et al. The natural history of thyroid function abnormalities after treatment for childhood cancer. Eur J Cancer 2007;43:1161-1170. (Pubitemid 46590737)
20. van Santen HM, Vulsma T, Dijkgraaf MG, et al. No damaging effect of chemotherapy in addition to radiotherapy on the thyroid axis in young adult survivors of childhood cancer. J Clin Endocrinol Metab 2003;88:3657-3663. (Pubitemid 37034510)
21. Berger C, Le-Gallo B, Donadieu J, et al. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrowtransplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant 2005; 35:991-995. (Pubitemid 40711836)
22. Ishiguro H, Yasuda Y, Tomita Y, et al. Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J Clin Endocrinol Metab 2004;89:5981-5986. (Pubitemid 39628403)
23. Miyoshi Y, Ohta H, Hashii Y, et al. Endocrinological analysis of 122 Japanese childhood cancer survivors in a single hospital. Endocr J 2008;55:1055-1063.
24. Acharya S, Sarafoglou K, LaQuaglia M, et al. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer 2003;97:2397-2403. (Pubitemid 36542477)
25. Ronckers CM, Sigurdson AJ, Stovall M, et al. Thyroid cancer in childhood cancer survivors:A detailed evaluation of radiation dose response and its modifiers. Radiat Res 2006;166:618-628. (Pubitemid 44477715)
26. Inskip PD, Curtis RE. New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer 2007;121: 2233-2240.
27. Louie AD, Robison LL, Bogue M, et al. Validation of self-reported complications by bone marrow transplantation survivors. Bone Marrow Transplant 2000;25:1191-1196. (Pubitemid 30345255)
28. National Centers for Health Statistics. Net differences in interview data on chronic conditions and information derived from medical records. Series 2, Number 57. Rockville: US Department of Health, Education, and Welfare; 1973. Available at http://www.cdc.gov/ nchs/data/series/sr-02/sr02-057.pdf [accessed on 3/27/2009].
29. Darzy KH, Shalet SM, Circadian and stimulated thyrotropin secretion in cranially irradiated adult cancer survivors. J Clin Endocrinol Metab 2005;90:6490-6497.